Ra Pharmaceuticals to Present at Upcoming Investor Conferences
May 14 2019 - 7:00AM
Business Wire
Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today announced that
senior management will present at the following upcoming investor
conferences:
- The UBS Global Healthcare Conference
2019 on Tuesday, May 21, 2019 at 9:00 a.m. E.T. The conference will
be held at the Grand Hyatt New York in New York, NY.
- The 2019 RBC Capital Markets Global
Healthcare Conference on Wednesday, May 22, 2019 at 11:30 a.m. E.T.
The conference will be held at the InterContinental New York
Barclay in New York, NY.
The presentations will be webcast live and can be accessed by
visiting the investor relations section of the Company’s website,
www.rapharma.com. A replay of each presentation will be available
and archived on the site for three weeks.
About Ra Pharmaceuticals
Ra Pharmaceuticals is a clinical-stage biopharmaceutical company
focused on leading the field of complement biology to bring
innovative and accessible therapies to patients with rare diseases.
The Company discovers and develops peptides and small molecules to
target key components of the complement cascade. For more
information, please visit: www.rapharma.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190514005074/en/
Investors:Ra PharmaceuticalsNatalie Wildenradt,
617-674-9874nwildenradt@rapharma.com
Media:Argot PartnersDavid Rosen,
212-600-1902david.rosen@argotpartners.com
Ra Pharmaceuticals (NASDAQ:RARX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ra Pharmaceuticals (NASDAQ:RARX)
Historical Stock Chart
From Sep 2023 to Sep 2024